ProfileGDS4718 / 204735_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 60% 78% 68% 64% 70% 53% 68% 71% 66% 67% 67% 79% 73% 72% 68% 70% 69% 72% 64% 69% 71% 68% 68% 65% 66% 73% 68% 70% 72% 70% 73% 75% 67% 72% 65% 64% 75% 70% 82% 65% 72% 70% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.7291268
GSM549102patient 115, normal, homogenized [OPG study]6.1392560
GSM549104patient 119, normal, homogenized [OPG study]7.7002678
GSM549108patient 138, normal, homogenized [OPG study]6.6770768
GSM549119patient 077, normal, homogenized [OPG study]6.3681664
GSM549133patient 032, cancer, homogenized [OPG study]6.9244570
GSM549139patient 042, cancer, homogenized [OPG study]5.6493653
GSM549099patient 107, normal, homogenized [OPG study]6.6566768
GSM549109patient 139, normal, homogenized [OPG study]6.9172171
GSM549110patient 046, normal, homogenized [OPG study]6.5349166
GSM549114patient 063, normal, homogenized [OPG study]6.6257667
GSM549122patient 082, normal, homogenized [OPG study]6.6787567
GSM549134patient 033, cancer, homogenized [OPG study]7.7214879
GSM549136patient 036, cancer, homogenized [OPG study]7.1607573
GSM549140patient 044, cancer, homogenized [OPG study]7.1290472
GSM549111patient 047, normal, homogenized [OPG study]6.7255468
GSM549113patient 057, normal, homogenized [OPG study]6.9382670
GSM549132patient 031, cancer, homogenized [OPG study]6.7785369
GSM549137patient 038, cancer, homogenized [OPG study]7.1143172
GSM549142patient 047, cancer, homogenized [OPG study]6.4454464
GSM549100patient 110, normal, homogenized [OPG study]6.7689969
GSM549107patient 135, normal, homogenized [OPG study]6.9864971
GSM549115patient 068, normal, homogenized [OPG study]6.6948168
GSM549116patient 072, normal, homogenized [OPG study]6.7404868
GSM549120patient 078, normal, homogenized [OPG study]6.469665
GSM549131patient 030, cancer, homogenized [OPG study]6.5902466
GSM549118patient 074, normal, homogenized [OPG study]7.143673
GSM549129patient 027, cancer, homogenized [OPG study]6.728568
GSM549123patient 088, normal, homogenized [OPG study]6.8482470
GSM549124patient 006, cancer, homogenized [OPG study]6.9729572
GSM549126patient 015, cancer, homogenized [OPG study]6.8869870
GSM549128patient 025, cancer, homogenized [OPG study]7.2581773
GSM549103patient 117, normal, homogenized [OPG study]7.187475
GSM549117patient 073, normal, homogenized [OPG study]6.5758967
GSM549138patient 041, cancer, homogenized [OPG study]7.1178372
GSM549141patient 045, cancer, homogenized [OPG study]6.5107265
GSM549130patient 028, cancer, homogenized [OPG study]6.3843164
GSM549101patient 111, normal, homogenized [OPG study]7.2944675
GSM549105patient 128, normal, homogenized [OPG study]6.8553970
GSM549106patient 134, normal, homogenized [OPG study]8.2994782
GSM549112patient 048, normal, homogenized [OPG study]6.4395165
GSM549125patient 011, cancer, homogenized [OPG study]7.0640972
GSM549127patient 024, cancer, homogenized [OPG study]6.9299170
GSM549135patient 035, cancer, homogenized [OPG study]7.7288978